These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4061059)

  • 41. Characteristics of women seeking treatment for premenstrual syndrome.
    Harrison WM; Endicott J; Nee J; Glick H; Rabkin JG
    Psychosomatics; 1989; 30(4):405-11. PubMed ID: 2798733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial effect of oral estriol treatment in postmenopausal women.
    Englund DE; Johansson ED
    Acta Obstet Gynecol Scand; 1980; 59(5):449-51. PubMed ID: 7446012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
    Sundblad C; Hedberg MA; Eriksson E
    Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.
    Gonda X; Telek T; Juhász G; Lazary J; Vargha A; Bagdy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1782-8. PubMed ID: 18721843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Percutaneous estrogen replacement therapy. An alternative for oral treatment].
    Holst J; von Schoultz B
    Duodecim; 1983; 99(20):1457-62. PubMed ID: 6653450
    [No Abstract]   [Full Text] [Related]  

  • 46. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
    Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
    Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of symptoms of premenstrual tension in hysterectomized women.
    Bäckström CT; Boyle H; Baird DT
    Br J Obstet Gynaecol; 1981 May; 88(5):530-6. PubMed ID: 7195277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations.
    Natale V; Albertazzi P; Zini M; Di Micco R
    BJOG; 2001 Mar; 108(3):286-90. PubMed ID: 11281470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy.
    Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL
    Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe premenstrual syndrome and bipolar disorder: a tragic confusion.
    Studd J
    Menopause Int; 2012 Jun; 18(2):82-6. PubMed ID: 22611228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
    Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
    Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives.
    Sveindóttir H; Bäckström T
    Acta Obstet Gynecol Scand; 2000 May; 79(5):405-13. PubMed ID: 10830769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chinese version of Daily Record of Severity of Problems: reliability and validity.
    Wu L; He Z; Zhao H; Ma D; Zhang S; Deng H; Liang T
    J Adv Nurs; 2013 Feb; 69(2):449-56. PubMed ID: 22737971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone therapy for reproductive depression in women.
    Studd J
    Post Reprod Health; 2014 Dec; 20(4):132-7. PubMed ID: 25398672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depressive episodes in premenstrual syndrome.
    Mortola JF; Girton L; Yen SS
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1682-7. PubMed ID: 2603926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy.
    Wihlbäck AC; Sundström-Poromaa I; Nyberg S; Bäckström T
    Neuroendocrinology; 2001 Jun; 73(6):397-407. PubMed ID: 11408781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagen.
    Holst J; Cajander S; von Schoultz B
    Acta Obstet Gynecol Scand; 1983; 62(3):267-70. PubMed ID: 6624399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.